JPS6272604A - Skin cosmetic - Google Patents
Skin cosmeticInfo
- Publication number
- JPS6272604A JPS6272604A JP21315685A JP21315685A JPS6272604A JP S6272604 A JPS6272604 A JP S6272604A JP 21315685 A JP21315685 A JP 21315685A JP 21315685 A JP21315685 A JP 21315685A JP S6272604 A JPS6272604 A JP S6272604A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- glucoside
- cosmetic
- styrene
- healthy state
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Cosmetics (AREA)
Abstract
Description
【発明の詳細な説明】
(発明の分野)
本発明は、スチロールグルコシドを配合してなる皮膚の
水分保持機能を元通し得る皮膚化粧料に関する。DETAILED DESCRIPTION OF THE INVENTION (Field of the Invention) The present invention relates to a skin cosmetic containing styrene glucoside that can restore the moisture retention function of the skin.
(従来技術)
従来より、健常な皮膚を保持する為に、皮膚に適度な水
分と油分を与える親水性の皮膚保湿剤と油性の皮膚柔軟
剤を皮膚化粧料に配合することが行われている。(Prior art) In order to maintain healthy skin, hydrophilic skin moisturizers and oily skin softeners that provide appropriate moisture and oil content to the skin have traditionally been blended into skin cosmetics. .
皮膚保湿剤には、グリセリン、プロピレングリコール、
ポリエチレングリコール、ピロ・リドンカルボン酸塩等
が利用されているが、これらは、皮膚の最外層である角
質層の水分を吸水して、かえって皮膚の水分を損失する
原因となることがあり、また、多量に含有する皮膚化粧
料にあっては、べたつくなどの異和感を与えるなど、必
ずしも満足出来るものではなかった。Skin moisturizers include glycerin, propylene glycol,
Polyethylene glycol, pyrolidone carboxylate, etc. are used, but these can absorb moisture from the stratum corneum, the outermost layer of the skin, and cause moisture loss in the skin. However, skin cosmetics that contain a large amount of these substances are not always satisfactory, as they give an unpleasant feeling such as stickiness.
また、皮膚柔軟剤には、流動パラフィン、ワセリン、オ
リーブ油、スクアラン、ラノリン、合成エステル油等が
利用されているが、これらも、表皮よりの水分蒸散を充
分に防ぐ程変に皮膚化粧料に含有せしめるときには、皮
膚の正常なる新陳代謝を阻害する原因となるなどの欠点
を有していた。In addition, liquid paraffin, petrolatum, olive oil, squalane, lanolin, synthetic ester oils, etc. are used as skin softeners, but these are also included in skin cosmetics in such amounts that they sufficiently prevent water evaporation from the epidermis. When exposed to skin, it has disadvantages such as inhibiting the normal metabolism of the skin.
(発明の開示)
本発明者等は、皮膚保湿剤、皮膚柔軟剤にみられる上記
の欠・点に鑑み、それら配合剤の物理的作用による表皮
への水分補給あるいは表皮よりの水分蒸散防止のみに依
存するのではなく、皮膚が本来備えている水分保持機能
を元通することによって皮膚を健常な状態に保持し、あ
るいは修復するような皮膚化粧料を提供することを目的
として鋭意研究した結果、スチロールグルコシドを配合
してなる皮膚化粧料が該目的に合致する効果を発現する
ことを見出し、本発明を完成した。(Disclosure of the Invention) In view of the above-mentioned shortcomings and drawbacks of skin moisturizers and skin softeners, the present inventors have determined that the physical effects of these ingredients can be used to replenish moisture to the epidermis or prevent water evaporation from the epidermis. The result of intensive research aimed at providing skin cosmetics that maintain or repair the skin in a healthy state by restoring the skin's inherent moisture retention function, rather than relying on it. The present invention was completed based on the discovery that a skin cosmetic containing styrene glucoside exhibits an effect that meets the above objectives.
皮膚の水分は、真皮から表皮の基底細胞層、更に角’R
Mへと外層に向うにつれて減少する水分含量の勾配に沿
って、常に皮膚内部から外層部へ移動し、角質層を通じ
て外部へ蒸散しているが、この水分蒸散は主に顆粒層頂
部の層板顆粒から角質層に及ぶ緻密な細胞組織からなる
防御機能(バリヤー機能)により制御されており、該蒸
散量〔不感蒸泄(Transepidermal Wa
ter 1oss )値(°以下、TWL値という)
で表わされる)は例えば健常な皮膚の正常な状態におけ
る前腕部皮表では0.2〜0.3 Q / cd /
h r (7)範囲、通常!、tO,2511i1 /
cti / h r程度以下に保持されているbこれ
に対して、通常にみ°られる乾燥皮膚(ドライスキン)
あるいは老化皮膚にみられる乾燥皮膚では、その程度に
応じてTWL値は上記の範囲の上限値もしくはそれより
大きな値を示し、皮膚の水分保持機能が低下しているこ
とが認められる。これはそれら・乾燥皮膚の場合、角質
層の防御機能による通常の制御限界を超えた状態にある
か、あるいは該防御機能が衰えていることに由来するも
のである。Water in the skin is distributed from the dermis to the basal cell layer of the epidermis, and then to the keratin layer.
Moisture always moves from the inside of the skin to the outer layer along the gradient of water content, which decreases toward the outer layer of the skin, and transpires to the outside through the stratum corneum, but this water evaporation mainly occurs in the lamina at the top of the granular layer. It is controlled by a protective function (barrier function) consisting of dense cell tissue ranging from granules to the stratum corneum, and the amount of transpiration [Transepidermal Wa
ter 1oss ) value (hereinafter referred to as TWL value)
) is 0.2 to 0.3 Q / cd / on the skin surface of the forearm under normal conditions of healthy skin.
h r (7) Range, normal! ,tO,2511i1/
The cti/hr level is maintained below about
Alternatively, in dry skin such as aging skin, the TWL value shows the upper limit of the above range or a value larger than the upper limit depending on the degree of dryness, and it is recognized that the moisture retaining function of the skin is reduced. This is because, in the case of dry skin, the normal control limit of the protective function of the stratum corneum is exceeded, or the protective function is weakened.
従って、角質層及び層板顆粒の組織を緻密化し、その防
御機能を賦活することができれば、これによって皮膚の
水分保持機能が元通され、皮膚は健常な状態に保持され
る。と共に、更に乾燥皮膚の改善ないしは修復が可能と
なるのである。そこで、本発明者等は、植物の葉、葉柄
、機、■子などに存在することが知られているスチロー
ルグルコシドの人皮膚に対する作用効果に関して鋭意研
究した結果、本発明の皮膚化粧料が顆粒層頂部の看板顆
粒゛から角質層に至る組織を正常化し、皮膚それ自体の
水分保持機能を元通することにより、乾燥皮膚を改善し
、あるいは皮膚を健常な状態に保持してその老化を防ぎ
、皮膚に湿潤性(しっとり感)、柔軟性(°滑らか感)
、弾力性及び艶を与える美肌効果を有することを見出し
た。Therefore, if the structures of the stratum corneum and lamellar granules can be densified and their defense functions activated, the water retention function of the skin will be restored and the skin will be maintained in a healthy state. At the same time, dry skin can be further improved or repaired. Therefore, the present inventors conducted intensive research on the effects of styrene glucoside, which is known to be present in plant leaves, petioles, seeds, and seeds, on human skin. By normalizing the tissues from the top granules at the top of the layer to the stratum corneum and restoring the skin's own moisture retention function, it improves dry skin or maintains the skin in a healthy state to prevent aging. , moisture to the skin (moist feeling), flexibility (°smooth feeling)
It has been found that it has a beautifying effect on the skin by imparting elasticity and luster.
本発明の皮°膚化粧料の場合、従来の皮膚化粧料のごと
く前記の皮膚湿潤剤、皮膚柔軟剤を多量に配合する必要
がなく、皮膚の正常な生理機能が妨げられる虞れがない
。In the case of the skin cosmetics of the present invention, unlike conventional skin cosmetics, there is no need to incorporate large amounts of the above-mentioned skin moisturizers and skin softeners, and there is no risk of interfering with the normal physiological functions of the skin.
(発明の目的)
本発明の目的は、皮膚が本来備えている水分保持機能を
元通することによって皮膚を健常な状態に保持し、或い
は修復して、優れた美肌効果を有する皮膚化粧料を提供
するにある。(Objective of the Invention) The object of the present invention is to maintain or repair the skin in a healthy state by restoring the skin's inherent moisture retention function, and to provide a skin cosmetic that has excellent skin beautifying effects. It is on offer.
(発明の構成)
本発明は、植物より抽出して得られるスチロールグルコ
シドを配合してなることを特徴とする皮膚化粧料である
。(Structure of the Invention) The present invention is a skin cosmetic characterized by containing styrene glucoside extracted from plants.
(具体的な構成の説明)
本発明に用いるスチロールグルコシドは、植物の菜、葉
柄、根、欄干などに存在し、通常の脂質を抽出方法によ
って上記組織から抽出分離精製して得られることが知ら
れている。〔油化学、第20巻第10号、第85〜97
頁、1971年。(Explanation of specific structure) Styrene glucoside used in the present invention is known to be present in plants, petioles, roots, parapets, etc., and can be obtained by extracting, separating and purifying the above-mentioned tissues using ordinary lipid extraction methods. It is being [Oil Chemistry, Vol. 20, No. 10, No. 85-97
Page, 1971.
日本農芸化学会誌、第47巻、第3号、第229〜23
0頁、1973等参照〕また、審査(ツルナ、Tetr
agonia tetragonides )より抽出
して得られたスチロールグルコシド(β−5itost
eryl−β−D−glucoside など)がマ
ウス拘束水浸ストレス潰瘍に対する抑制作用を有すると
の報告がある。〔薬学雑誌、第103.8、第1号、第
43〜48頁、1983年参照〕本発明者等は、特に含
有量が多いか或いはスチロールグルコシドの抽出が容易
である、例えば、玄米、大豆、審査、ジャガイモ、アル
ファルファなどの植物より後記の実験例のごとくスチロ
ールグルコシド類を前記の参照文献の記載に準じて抽出
分離精製し、このスチロールグルコシド類を各種皮膚化
粧料に配合して後記の諸試験を実施した。Journal of the Japanese Society of Agricultural Chemistry, Volume 47, No. 3, Nos. 229-23
0 page, 1973, etc.] Also, the examination (Tsurna, Tetr
styrene glucoside (β-5itost) obtained by extraction from Agonia tetragonides).
It has been reported that eryl-β-D-glucoside, etc.) has an inhibitory effect on restraint water immersion stress ulcers in mice. [Refer to Pharmaceutical Journal, No. 103.8, No. 1, pp. 43-48, 1983] The present inventors have investigated the use of rice grains containing particularly high styrene glucosides or from which it is easy to extract styrene glucoside, such as brown rice and soybean. , examination, styrene glucosides were extracted, separated and purified from plants such as potatoes and alfalfa as described in the experimental examples described below, and the styrene glucosides were blended into various skin cosmetics to be used in the various manners described below. A test was conducted.
(実験例)
実験例(1)・・・・・・第1表参照
■ 玄米(秋田産コシヒカリ) 10 kgを粉砕して
粒径0.1〜0.5Mの玄米粉末を得た。(Experimental Example) Experimental Example (1)...See Table 1 ■ 10 kg of brown rice (Koshihikari from Akita) was ground to obtain brown rice powder with a particle size of 0.1 to 0.5M.
■ この粉末を1001のクロロホルム−メタノール混
液(クロロホルム:メタノ°−ル=2:IV/V、以下
単に2:1と略記する)で温度50〜60″Cに加熱撹
拌しながら3回抽出した。(2) This powder was extracted three times with 1001 chloroform-methanol mixture (chloroform:methanol = 2:IV/V, hereinafter simply abbreviated as 2:1) at a temperature of 50-60''C while stirring.
■ この抽出液をFolch 法で3回水洗した後、ク
ロロホルム層を減圧濃縮して全脂質のクロロホルム溶液
10gを得た。(全脂質算出量300g)■ この溶液
をケイ酸1kgのカラムに注入し、再に各々101のク
ロロホルム及びアセトンを順次注入し、アセトン溶出液
を濃縮して糖脂質区分309を得た。(2) This extract was washed with water three times using the Folch method, and the chloroform layer was concentrated under reduced pressure to obtain 10 g of a total lipid solution in chloroform. (Calculated amount of total lipids: 300 g) ■ This solution was injected into a column containing 1 kg of silicic acid, and again 101 chloroform and acetone were injected in sequence, and the acetone eluate was concentrated to obtain glycolipid section 309.
■ 次にこの糖脂質をケイ酸カラムクロマトグラフィー
に供し、クロロホルム−アセトン混液(7,5:2.5
〜6.5:8.5)の溶出液を濃縮して、粗スチロール
グルコシド7gを得た。■ Next, this glycolipid was subjected to silicic acid column chromatography, and a chloroform-acetone mixture (7.5:2.5
The eluate of ~6.5:8.5) was concentrated to obtain 7 g of crude styrene glucoside.
■ 更にこの粗スチロールグルコシドをケイ酸カラムク
ロマトグラフィーに供し、クロロホルム−メタノール混
液(8:2)で処理して不純分を除いた後、クロロホル
ム−メタノール混i(7:3)で溶出し、この溶出液を
集め濃縮し、クロロホルムを減圧下で留去し、精製し、
目的とするスチロールグルコシド4.59を得た。■ This crude styrene glucoside was further subjected to silicic acid column chromatography, treated with a chloroform-methanol mixture (8:2) to remove impurities, and then eluted with a chloroform-methanol mixture (7:3). The eluate was collected and concentrated, chloroform was distilled off under reduced pressure, and purified.
4.59 of the desired styrene glucoside was obtained.
上記で抽出して得られたスチロールグルコシドは、第2
表の溝造式で表わされるβ−シトステリルβ−D−グル
コシドを主成分とし、池にスティグマステリルβ−D−
グルコシド、Δ7−スチイクマステリルβ−D−グルコ
シドが含有するものであり、スチロールグルコシド1と
して95.7wt%(純度)含有するものであった。The styrene glucoside obtained by the above extraction is
The main component is β-sitosteryl β-D-glucoside, which is expressed by the Mizozo formula in the table, and stigmasteryl β-D-
It contained glucoside, Δ7-stikmasteryl β-D-glucoside, and contained 95.7 wt % (purity) of styrene glucoside 1.
尚、スチロールグルコシドの確認及び純度はガスクロマ
トグラフィー質量分析計、核磁気共鳴スFit5
1 2<巨11i−1残
渣
第 2 表
H
β−シトステリルβ−D−グルコシド
実験例(2)
審査(ツルナ)の全草乾物10にりより、前記実験例(
1)の抽出分離精製方法と同様にして目的とするスチロ
ールグルコシド(純度96.5wt%)を6.7g得た
。The confirmation and purity of styrene glucoside was confirmed using gas chromatography mass spectrometer and nuclear magnetic resonance Fit5.
1 2 < Giant 11i-1 remaining
Residue No. 2 Table H β-sitosteryl β-D-glucoside Experimental Example (2) The experimental example (
6.7 g of the target styrene glucoside (purity 96.5 wt%) was obtained in the same manner as the extraction separation and purification method in 1).
このスチロールグルコシドの成分は玄米のスチロールグ
ルコシドと同様にβ−シトステリルβ−D−グルコシド
であった。The component of this styrene glucoside was β-sitosteryl β-D-glucoside, similar to the styrene glucoside of brown rice.
実験例(3)
アルファルファの全草乾物10kqより、前記実験例(
1)の抽出分離精製方法と同様にして目的とするスチロ
ールグルコシド(純度94.7 w t%)を6.57
得た。Experimental Example (3) From 10 kq of alfalfa whole plant dry matter, the experimental example (
The target styrene glucoside (purity 94.7 wt%) was extracted with 6.57 wt% in the same manner as the extraction separation purification method in 1).
Obtained.
このスチロールグルコシドの主成分は玄米及び審査のス
チロールグルコシドと同様にβ−シトステリルβ−D−
グルコシドであった。The main component of this styrene glucoside is β-sitosteryl β-D-
It was a glucoside.
本発明に於いて、前記スチロールグルコシドの配合量は
、皮膚化粧料(組成物)の総量を基準として0.1〜5
w t%の範囲が好適である。配合量が0.1 w
t%未満では効果が充分に達成されず、一方5 w t
%を超えてもその増加分に見合った効果の向上は望めな
い。In the present invention, the blending amount of the styrene glucoside is 0.1 to 5% based on the total amount of the skin cosmetic (composition).
A range of wt% is preferred. The blending amount is 0.1w
Below t %, the effect is not fully achieved, while 5 w t
%, it cannot be expected to improve the effect commensurate with the increase.
本発明の皮膚化・糖料は、例えばローシ冒ン類、乳液類
、クリーム類、パック類等に適用することができる。The skin softening/sugar agent of the present invention can be applied to, for example, lotions, emulsions, creams, packs, etc.
尚、本発明の皮膚化粧料には上記の他に色素、香料、防
腐剤、界面活性剤、顔料、抗酸化剤等を本発明の目的を
達成する範囲内で適宜配合することができる。In addition to the above, pigments, fragrances, preservatives, surfactants, pigments, antioxidants, and the like may be appropriately incorporated into the skin cosmetic of the present invention within a range that achieves the object of the present invention.
以下、実施例及び試験例に基づいて本発明を詳説する。The present invention will be explained in detail below based on Examples and Test Examples.
尚、TWL値、TWL値変化率、角PR/irlターン
オーバー速度、角質細胞の剥離特性の測定方法或いは評
価方法を下記に示した。The methods for measuring or evaluating the TWL value, rate of change in TWL value, angular PR/irl turnover rate, and exfoliation characteristics of corneocytes are shown below.
(1)TWL値
密閉した皮表上の空気の一定時間内の湿度変化を電気抵
抗にて測定する方法を用いた。(1) TWL value A method was used to measure the humidity change in the air above the sealed skin surface over a certain period of time using electrical resistance.
即ち、被試験者の皮表を測定用セルで密閉し、セルに強
制乾燥した空気を通気してセル内を乾燥空気で充分置換
した後、乾燥空気の通気を停止してその時°点でのセル
内の相対湿度RHs(%)を求め、次いで10分間放置
して再びセル内の相対湿度’RHIO(%)を測定し、
この時の湿度変化から下記の式によりTWL値を算出し
た。That is, the test subject's skin surface is sealed in a measurement cell, forced dry air is vented into the cell to fully replace the inside of the cell with dry air, and then the ventilation of dry air is stopped and the measurement is carried out at that point. Determine the relative humidity RHs (%) in the cell, then leave it for 10 minutes and measure the relative humidity 'RHIO (%) in the cell again.
The TWL value was calculated from the humidity change at this time using the following formula.
但し、Dt =測定温度下(t″C)での空気中の飽和
水蒸気の密度(寓g/l)
V :セルの容積(A’)
S :測定面積(d)
(2) TWL値変化率
皮膚に試料(皮膚化粧料)を塗布する以前と以後におけ
るTWL値をそれぞれ求め、その変化率を下記の式より
算出し、TWL低減効果(水分保持機能亢進効果)を評
価した。However, Dt = Density of saturated water vapor in the air at measurement temperature (t''C) (g/l) V: Cell volume (A') S: Measurement area (d) (2) TWL value change rate The TWL values before and after applying the sample (skin cosmetic) to the skin were determined, and the rate of change was calculated using the following formula to evaluate the TWL reduction effect (moisture retention function enhancement effect).
試料(皮膚化粧料)塗布以前のTWL値:TWLn試料
(皮膚化粧料)塗布以後のTWL値:TWLム(3)
角質層のターンオーバー速度測定方法蛍光色素のダン
ジルクロライドを白色ワセリン中に5重量%配合した軟
膏を作り、被検者の前腕部の皮膚に24時間閉塞貼布し
、角質層にダンジルクロライドを浸透結合させる。その
後同じ部位に1日2回(朝・夕)被検試料を塗布し、毎
日ダンジルクロライドの蛍光をしらべ、その蛍光が消滅
するまでの日数を皮膚角質層のターンオーバー速度とし
た。なお、通常の皮膚角質層のターンオーバー速度は1
4〜16日であるが、老化した皮膚においては18日前
後1このびる。それに対して老化防止効果が現れると1
2日前後にまで短縮される。TWL value before application of sample (skin cosmetic): TWLn TWL value after application of sample (skin cosmetic): TWLm (3)
Method for measuring the turnover rate of the stratum corneum: An ointment containing 5% by weight of the fluorescent dye danzyl chloride in white petrolatum is made, and the ointment is applied to the skin of the subject's forearm for 24 hours to inject danzyl chloride into the stratum corneum. osmotic bond. Thereafter, the test sample was applied to the same area twice a day (morning and evening), and the fluorescence of danzyl chloride was examined every day.The number of days until the fluorescence disappeared was defined as the turnover rate of the skin stratum corneum. Note that the normal turnover rate of the skin's stratum corneum is 1
It lasts for 4 to 16 days, but in aged skin it increases around 18 days. On the other hand, if the anti-aging effect appears, 1
It will be shortened to around 2 days.
(4)角質細胞の剥離特性
皮膚にスコッチテープにチバンメンディングテーブ)を
貼付し、これを剥離して皮表の角質細胞をテープに付着
せしめた。次にこの角質細胞の状態を走査型電子顕微鏡
によって詳細に観察し、第3表に示す判定基準に基づい
て、角質細胞の剥離特性を分類してその指数を求めた。(4) Peeling characteristics of keratinocytes Scotch tape (Tiban mending tape) was applied to the skin, and this was peeled off to allow the keratinocytes on the skin surface to adhere to the tape. Next, the condition of the keratinocytes was observed in detail using a scanning electron microscope, and the exfoliation characteristics of the keratinocytes were classified based on the criteria shown in Table 3, and their indices were determined.
第3表 角質細胞の剥離特性判定基準
なお、この角質細胞の剥離特性は、角質層の構造特性を
判断する指標となるものであって、一般に乾燥皮膚、老
化皮膚に於ては、細胞間着合力が弱く、またその構造の
緻密性も低い?−キから指数が高くなることが確認され
ている。Table 3 Criteria for Judging the Peeling Properties of Corneocytes The peeling properties of corneocytes serve as an index for determining the structural properties of the stratum corneum, and in general, in dry skin and aging skin, intercellular adhesion Is the resultant force weak and the structure less dense? It has been confirmed that the index becomes higher from -ki.
実施例1〜3 比較例1
〔スキン クリーム〕
前記実験例で得たスチロールグルコシドを配合して本発
明の実施例1〜3と比較例1のスキンク[(1)組成
(2) 調製法
ω成分及びの)成分を各々80”Cに加熱溶解した後混
合して、撹拌しっつ30”c迄冷却して各スキンクリー
ムを調製した。Examples 1 to 3 Comparative Example 1 [Skin Cream] Skin creams of Examples 1 to 3 of the present invention and Comparative Example 1 were prepared by blending the styrene glucoside obtained in the above experimental example [(1) Composition (2) Preparation method ω component Each skin cream was prepared by heating and dissolving the ingredients (and) respectively at 80"C, mixing, stirring and cooling to 30"C.
試験例1
実施例1〜3の本発明のスキンクリーム及び比較例1の
スキンクリームを適用した際の、それらの’I’WL値
及び角質細胞剥離特性に及ぼす影響を調べた。Test Example 1 When the skin creams of the present invention of Examples 1 to 3 and the skin cream of Comparative Example 1 were applied, their effects on 'I'WL values and keratin cell exfoliation properties were investigated.
(1)試験方法
60名の健常な普通の皮JRの被試験者(年令20〜2
5才の女性)を20名ずつ、3グループ(A、O及びE
グループ)に、また60名の通常の乾燥皮膚を示す被試
験者(年令20〜25才の女性)を20名ずつ、3グル
ープ(B。(1) Test method 60 healthy normal skinned JR test subjects (age 20-2)
3 groups (A, O and E) of 20 people each (5 years old female)
In addition, there were 60 test subjects (females aged 20 to 25 years old) with normal dry skin in 3 groups of 20 each (B).
D及びFグループ)に分けた。D and F groups).
試験に先立ち全被試験者の左右曲腕部皮表のTWL値を
測定し、各グループ毎に平均値を算出した。次に、被試
験者の前腕部皮表に、左前腕には全被試験者について比
較例1のスキンクリームを、また右前腕には、各グルー
プ毎にム及びBグループでは実施例1、C及びDグルー
プでは実施例2、E及びFグループでは実施例3の各ス
キンクリームを、1日2回(朝、夕)連続1力月塗布し
、最終塗布臼の翌日、全被試験者についてクリームを塗
布した左右前腕部皮表部分のTWL値を測定し、さらに
角質細胞剥離特性を評価した。Prior to the test, the TWL values on the skin surfaces of the left and right bent arms of all subjects were measured, and the average value was calculated for each group. Next, the skin cream of Comparative Example 1 was applied to the skin surface of the forearm of the test subjects, and the skin cream of Comparative Example 1 was applied to the left forearm for all the test subjects, and the skin cream of Example 1 and C was applied to the right forearm of each group. The skin cream of Example 2 was applied to Groups D and D, and the skin cream of Example 3 was applied to Groups E and F for one month continuously twice a day (morning and evening), and the cream was applied to all subjects on the day after the final application. The TWL value of the left and right forearm skin surface areas to which the product was applied was measured, and the keratin cell exfoliation properties were further evaluated.
尚、塗布試験終了後、医師により診断した結果では、全
被試験者の前腕部の皮膚及び体調に何ら異常は認められ
なかった。After the application test, a doctor diagnosed no abnormalities in the skin or physical condition of the forearm of any of the test subjects.
(2)結果
スキンクリーム塗布舘及び塗布後のTWL値それら’f
’WL値から求めたTWL値変化率並びに角質細胞剥離
特性の指数(何れの値も各グループ20名の平均値)を
第4表に示した。(2) Results of skin cream application and TWL values after application.
Table 4 shows the TWL value change rate determined from the WL value and the index of keratinocyte exfoliation properties (all values are average values of 20 people in each group).
第4表に示す結果より、下記の通り本発明の実施例1,
2及び3のスキンクリームの効果が認められた。From the results shown in Table 4, Example 1 of the present invention,
The effects of skin creams 2 and 3 were observed.
■ A、O及びEグループの健常な普通の皮、逍に於て
は、元々皮膚の水分保持機能が正常な状態に保持されて
いるので、本発明のスキンクリーム(実施例1,2及び
3)塗布の効果は顕在化しにくい状況にあるが、それで
も、比較例1に比して若干の改善が認められる。■ In the normal, healthy skin of groups A, O, and E, the moisture retention function of the skin is originally maintained in a normal state. ) Although the effect of coating is difficult to become apparent, a slight improvement is still observed compared to Comparative Example 1.
■ B、D及びFグループの乾燥皮膚に於ては、本発明
のスキンクリーム(実施例1,2及び3)を室布した右
前腕部皮表に、左前腕部皮表(比較例1のスキンクリー
ム)に比してT′WL値の著しい改善が認められ、その
値は健常皮膚と同等か、もしくはそれに近づいている。■ For dry skin in groups B, D and F, the skin surface of the right forearm coated with the skin cream of the present invention (Examples 1, 2 and 3) was applied to the skin surface of the left forearm (comparative example 1). A significant improvement in T'WL value was observed compared to skin cream), and the value was equal to or approaching that of healthy skin.
本発明のクリーム間の比較を行った・場合、・実施例3
において、水・分保持機能改善効果が最も高く、次いで
、実施例2,1の順であった。さらに、角質細胞剥離試
験についても同様な結果を得た。Example 3: Comparison between creams of the present invention
In Examples 2 and 1, the water/minute retention function improvement effect was the highest, followed by Examples 2 and 1. Furthermore, similar results were obtained in the corneum cell peeling test.
即ち、本発明の実施例1,2及び3のスキンクリームは
、ム、C並びにEグループにおいては健常な皮膚を保持
する効果を示し、また、B。That is, the skin creams of Examples 1, 2, and 3 of the present invention exhibited the effect of maintaining healthy skin in Groups B, C, and E;
D並びにFグループにおいては健常な皮膚゛に近付ける
効果を有することは明らかである。It is clear that groups D and F have the effect of bringing the skin closer to healthy skin.
これらの結果より、本発明の実施例1,2及び3のスキ
ンクリームに含まれるスチロールグルコシドが表皮細胞
に有効に作用し、角質層の細胞間結合能力を改善して、
その構造を緻密にし、皮膚の水分保持機能を亢進するこ
と、及び健常な皮膚の生理機能はこれを何ら阻害しない
安全性の高いものであることがわかる。−1・や1・
(以下声白)
試験例2
実施例3の本発明のスキンクリーム及び比較例1のスキ
ンクリームについて、それらの健常な皮膚及び老化乾燥
皮膚のTWL値及び角質層ターンオーバー速度に及ぼす
影響を調べた。From these results, the styrene glucoside contained in the skin creams of Examples 1, 2, and 3 of the present invention effectively acts on epidermal cells, improves the intercellular bonding ability of the stratum corneum, and
It can be seen that the structure is made denser and the water retention function of the skin is enhanced, and that it is highly safe and does not interfere with the physiological functions of healthy skin. -1・ya1・ (hereinafter referred to as white) Test Example 2 TWL values and stratum corneum turnover rates of healthy skin and aged dry skin for the skin cream of the present invention of Example 3 and the skin cream of Comparative Example 1. We investigated the effect on
(1)試験方法
新たに、Gグループとして、健常な普通の皮膚の被試験
者20名(年令20〜25才の女性)、及び■グループ
として老化による乾燥皮膚を示す被試験者20名(年令
50〜60才の女性)の計40名について、予め左右前
腕部皮表のTWL値を測定した後、左右前腕部にダンジ
ルクロライド含有軟膏を24時間閉塞貼布した。(1) Test method In the G group, 20 test subjects (females aged 20 to 25 years old) with normal healthy skin, and in the ■ group, 20 test subjects with dry skin due to aging ( For a total of 40 women (50 to 60 years old), the TWL values on the skin surface of the left and right forearms were measured in advance, and then ointment containing danzyl chloride was applied as an occluded patch on the left and right forearms for 24 hours.
次に、G及びHグループの全被試験者の左前腕部皮表に
比較例1のスキンクリームを、また右前腕部皮表には実
施例1のスキンクリームを各々1日2回(朝、夕)連続
1力月塗布し、毎日、その蛍光を調べた。最終塗布口の
翌日、全被試験者について、クリームを塗布した左右前
腕部皮表部分の’I’WL値を測定した。Next, the skin cream of Comparative Example 1 was applied to the skin surface of the left forearm of all subjects in Groups G and H, and the skin cream of Example 1 was applied to the skin surface of the right forearm twice a day (in the morning, Evening) The solution was applied continuously for one month, and the fluorescence was examined every day. On the day after the final application, the 'I'WL values of the skin surface areas of the left and right forearms to which the cream was applied were measured for all test subjects.
尚、塗布試験終了後、医師による診断結果では、全被試
験者の前腕部の皮膚及び体調に何ら異常は認められなか
った。After the completion of the application test, no abnormality was observed in the skin of the forearm or physical condition of all the test subjects according to the results of diagnosis by a doctor.
(2)結果
スキンクリーム塗布前及び塗布後のTWL値(各グルー
プ20名の平均値)、それらTWL値から求めたTWL
値変化率並びに角質層ターンオーバー速度(各グループ
20名の平均値)を第5表に示した。(2) Results TWL values before and after skin cream application (average value of 20 people in each group), TWL calculated from these TWL values
Table 5 shows the value change rate and the stratum corneum turnover rate (average values for 20 people in each group).
(以テ°景品)
第5表に示す結果より、下記の通り本発明の実施例3の
スキンクリームの効果が認められた。(Hereinafter referred to as prize) From the results shown in Table 5, the effects of the skin cream of Example 3 of the present invention were recognized as follows.
■ Gグループの健常な普通の皮膚に於ては、皮膚の機
能状況が、正常に保持されていることから、本発明のス
キンクリーム(実施例3)により角質層ターンオーバー
速度の元通は認められなかった。また、TWL値につい
ては、試験例1と同様な結果を得た。■ Since the functional status of the skin was maintained normally in the healthy normal skin of Group G, it was confirmed that the skin cream of the present invention (Example 3) restored the turnover rate of the stratum corneum. I couldn't. Further, regarding the TWL value, the same results as in Test Example 1 were obtained.
■ Hグループの老化乾燥皮膚に於ては、本発明のスキ
ンクリーム(実施例3)を塗布した右前腕部皮表に、左
曲腕部皮表(比較例1のスキンクリーム塗布)に比し゛
て、角質層ターンオーバー逮変の元通(短縮化)が認め
られ、その値は正常皮膚の値に近付くものであった。T
WL値については、試験例1の通常の乾燥皮膚で認めら
れたと同様に本発明のクリーム(実施例3)塗布により
、著しい改善(TWL値の低下)を示し、正常人の値と
同等か、もしくは、その値に近付くものである。■ In the aged dry skin of group H, the skin surface of the right forearm to which the skin cream of the present invention (Example 3) was applied was compared to the skin surface of the left curved arm (to which the skin cream of Comparative Example 1 was applied). A normalization (shortening) of the turnover of the stratum corneum was observed, and the value approached that of normal skin. T
Regarding the WL value, application of the cream of the present invention (Example 3) showed a significant improvement (reduction in TWL value), similar to what was observed in normal dry skin in Test Example 1, and it was found that it was equivalent to the value of a normal person. Or something close to that value.
即ち、本発明の実施例1のスキンクリームは、老化乾燥
皮膚の角質層ターンオーバー速度を健常な皮膚のものに
近付け、且つ、水分保持機能を高めるものと言える。That is, it can be said that the skin cream of Example 1 of the present invention brings the turnover rate of the stratum corneum of aged dry skin closer to that of healthy skin, and enhances the water retention function.
試験例3
比較例1及び実施例1〜3のスキンクリームを乾燥皮膚
を訴える被試験老各々30名(26〜34才の女性)に
1日2回(蛸、夕)連続1力月間塗布した。医師による
診断の結果では、全被試験者の皮膚及び体調に異常は認
められ〜なかった。Test Example 3 The skin creams of Comparative Example 1 and Examples 1 to 3 were applied to each of 30 elderly test subjects (women aged 26 to 34) complaining of dry skin twice a day (in the evening) for one consecutive month. . As a result of the diagnosis by the doctor, no abnormality was observed in the skin or physical condition of all the test subjects.
クリームを塗布した後の皮膚に湿潤性(しっとり感)、
柔軟性(滑らか感)、弾力性及び艶を与える効果を全被
試験者について調査した結果を第6表に示した。Moisture (moist feeling) on the skin after applying the cream,
Table 6 shows the results of a survey on all test subjects regarding the effects on flexibility (smooth feel), elasticity, and gloss.
第6表の結果から明らかなごとく、スチロールグルコシ
ドを含有する実施例1〜3のスキンクリームは比較例1
のスキンクリームに比して顕著にQ6表
胸7
実施例4〜5、比較例2
〔スキンローシラン(二層型)〕
実施例1と同様に前記実験例で得たスチロールグルコシ
ドを配合して各スキンローシランを調製し、諸試験を実
施した。As is clear from the results in Table 6, the skin creams of Examples 1 to 3 containing styrene glucoside were the same as those of Comparative Example 1.
Q6 Table Chest 7 Examples 4 to 5, Comparative Example 2 [Skin Lo Silane (Two-layer type)] Similar to Example 1, the styrene glucoside obtained in the above experimental example was blended. Each skin low silane was prepared and various tests were conducted.
(1)組成
(2)調製法
成分(A)、03)を各々均一に溶解した後、成分く(
転)と成分(2)を混合撹拌分散し、次いで容器に充填
する。(1) Composition (2) Preparation method After uniformly dissolving each component (A) and 03),
(2) and component (2) are mixed, stirred and dispersed, and then filled into a container.
使用時には内容物を均一に振盪分散して皮膚に塗布する
。When using, shake and disperse the contents evenly and apply to the skin.
試映例4
比較例2および実施例4〜5のスキンローシランを乾燥
皮膚を訴える被試験者各30名(年令26〜34才の女
性)に1日2回(朝、夕)連続1ケ月間塗布した。医師
による診断の結果では、全被試訣者の皮膚および体調に
異常は認められなかった。Preview Example 4 The skin lotion silanes of Comparative Example 2 and Examples 4 to 5 were given to 30 test subjects (women aged 26 to 34 years old) who complained of dry skin twice a day (morning and evening) in a row. I applied it for a month. Diagnosis by a doctor revealed no abnormalities in the skin or physical condition of all subjects.
次にスキンローシランを塗布した後の皮膚に湿潤性(し
っとり感)、柔軟性(滑らか感)、弾力性および艶を与
える効果を全被試験者について調査した結果を第7表に
示した。Next, Table 7 shows the results of a survey on all test subjects to determine the effect of applying Skin Losilane on the skin, which imparts moisture (moist feeling), flexibility (smooth feel), elasticity, and luster.
第 7 表
@7表の結果から明らかなように、本発明ノ実濃側4〜
5のスキンローシクンはいずれも比較例2よりもすぐれ
た結果を示すが、特に実施例5のスキンローリ3ンの場
合に顕著な皮膚改善効果が認められる。As is clear from the results in Table 7
All Skin Lolicons No. 5 showed better results than Comparative Example 2, but in particular, Skin Lolicine 3 of Example 5 showed a remarkable skin improvement effect.
(発明の効果)
本発明のスチロールグルコシドを配合してなる皮膚化粧
料は、皮+iが本来備え、ている水分保持機能を冗′進
することによって、皮膚を健常な状態に保持°し或いは
修復して皮膚に湿潤性、柔軟性、弾°力性及び艶を与え
、優れた美肌効果を有する皮膚化粧料を提供するもので
ある。(Effects of the Invention) The skin cosmetics containing the styrene glucoside of the present invention maintain or repair the skin in a healthy state by enhancing the moisture retention function that skin+i inherently has. The present invention provides a skin cosmetic that imparts moisture, flexibility, elasticity and luster to the skin, and has an excellent skin beautifying effect.
Claims (1)
してなることを特徴とする皮膚化粧料。A skin cosmetic characterized by containing styrene glucoside extracted from plants.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP21315685A JPH075446B2 (en) | 1985-09-25 | 1985-09-25 | Skin cosmetics |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP21315685A JPH075446B2 (en) | 1985-09-25 | 1985-09-25 | Skin cosmetics |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS6272604A true JPS6272604A (en) | 1987-04-03 |
JPH075446B2 JPH075446B2 (en) | 1995-01-25 |
Family
ID=16634492
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP21315685A Expired - Lifetime JPH075446B2 (en) | 1985-09-25 | 1985-09-25 | Skin cosmetics |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH075446B2 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5565207A (en) * | 1990-09-19 | 1996-10-15 | Pola Kasei Kogyo Kabushiki Kaisha | Scalp moisturizer and external skin preparation |
JP2007254412A (en) * | 2006-03-24 | 2007-10-04 | Kuraray Co Ltd | External preparation for skin for prevention and/or improvement of wrinkles |
JP2008247786A (en) * | 2007-03-29 | 2008-10-16 | Naris Cosmetics Co Ltd | External preparation for skin |
JP2008247787A (en) * | 2007-03-29 | 2008-10-16 | Naris Cosmetics Co Ltd | External preparation for skin |
JP2009221173A (en) * | 2008-03-18 | 2009-10-01 | Naris Cosmetics Co Ltd | Keratin status ameliorator |
CN105997738A (en) * | 2016-07-12 | 2016-10-12 | 广州丹奇日用化工厂有限公司 | Skincare essence containing tetragonia tetragonioides extract |
JP2017105741A (en) * | 2015-12-12 | 2017-06-15 | オリザ油化株式会社 | Promotor for production of glucosylceramide and expression of metabolism gene in skin |
-
1985
- 1985-09-25 JP JP21315685A patent/JPH075446B2/en not_active Expired - Lifetime
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5565207A (en) * | 1990-09-19 | 1996-10-15 | Pola Kasei Kogyo Kabushiki Kaisha | Scalp moisturizer and external skin preparation |
JP2007254412A (en) * | 2006-03-24 | 2007-10-04 | Kuraray Co Ltd | External preparation for skin for prevention and/or improvement of wrinkles |
JP2008247786A (en) * | 2007-03-29 | 2008-10-16 | Naris Cosmetics Co Ltd | External preparation for skin |
JP2008247787A (en) * | 2007-03-29 | 2008-10-16 | Naris Cosmetics Co Ltd | External preparation for skin |
JP2009221173A (en) * | 2008-03-18 | 2009-10-01 | Naris Cosmetics Co Ltd | Keratin status ameliorator |
JP2017105741A (en) * | 2015-12-12 | 2017-06-15 | オリザ油化株式会社 | Promotor for production of glucosylceramide and expression of metabolism gene in skin |
CN105997738A (en) * | 2016-07-12 | 2016-10-12 | 广州丹奇日用化工厂有限公司 | Skincare essence containing tetragonia tetragonioides extract |
Also Published As
Publication number | Publication date |
---|---|
JPH075446B2 (en) | 1995-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60104423T2 (en) | NEW COMPOUNDS OF THE FAMILY OF N-ACYLAMINOAMIDES, COMPOSITIONS AND USES THEREIN | |
KR101490762B1 (en) | Cosmetic composition comprising the polysaccharide of Hibiscus esculentus as active ingredient | |
KR101425031B1 (en) | Cosmetic composition for anti-irritation and skin moisturization containing Citrus junos Siebold seed oil and Mangifera Indica seed oil | |
KR100501399B1 (en) | Cosmetic Compostion for Preventing Skin Aging Comprising Plant Extract as Oriental Medicine Stabilized in Nanoliposome | |
JPS61271205A (en) | Skin cosmetic | |
BRPI0620949A2 (en) | use of an unsaponifiable extract of vegetable pulp in the treatment of cutaneous aging | |
JP2000128765A (en) | Skin cosmetic | |
KR101574558B1 (en) | Cosmetic composition containing ginsenoside Rd, Rb2 and Bambusae Caulis in Taeniam extracts | |
JPS6272604A (en) | Skin cosmetic | |
KR101078888B1 (en) | A cosmetic composition comprising tissue cultured Echinaceae adventitious roots and an preparing method thereof | |
KR102085052B1 (en) | Composition for anti-inflammatory or moisturizing on skin comprising plant extract | |
KR100513902B1 (en) | Cosmetic Compositions Comprising Extract from Panax ginseng(C.A.MEY) for Preventing Skin Aging | |
JPS61286307A (en) | Skin cosmetic | |
DE60225239T2 (en) | Caramides, compositions containing them and their uses | |
KR100538078B1 (en) | Cosmetic Compositions Comprising Panax ginseng (C.A. MEY) Extract and Plant Extracts as Oriental Medicine for Preventing Skin Aging | |
KR101286140B1 (en) | Cosmetic composition for moisturizing and anti-irritation of skin containing polysaccharide from nelumbo nucifera rhizome | |
KR101825599B1 (en) | Composition of skin external application for moisturizing the skin containing Oldenlandia diffusa extracts | |
KR102044935B1 (en) | Whitening or moisturizing cosmetic composition comprising the extract of Cicer Arietinum | |
JPH0764701B2 (en) | Skin cosmetics | |
KR100570094B1 (en) | Oriental Skin Care Cosmeceutical Composition for Oral Administration Containing Galenical Extract | |
JP2000169332A (en) | Sebum secretion inhibitor and skin cosmetic | |
KR102502286B1 (en) | Composition without skin irritation and excellent skin moisturizing effect | |
KR102629711B1 (en) | Cosmetic Composition Comprising Exosome isolated From Dioscorea Japonica Thunb. As Active Ingredient | |
JP2702754B2 (en) | Skin cosmetics | |
KR102132538B1 (en) | Manufactureing method for cosmetic booster and cosmetic booster by the same and cosmetic composition having the same using rice bran extract |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EXPY | Cancellation because of completion of term |